Hao Shao

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Top Venues

Science signaling

Cancer research

Chemical science

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Julian R Braxton, Hao Shao, Eric Tse, Jason E Gestwicki, Daniel R Southworth
Asymmetric apical domain states of mitochondrial Hsp60 coordinate substrate engagement and chaperonin assembly. bioRxiv : the preprint server for biology (2023)
Duygu Kuzuoğlu-Öztürk, Ozlem Aksoy, Christin Schmidt, Robin Lea, Jon D Larson, Ryan R L Phelps, Nicole Nasholm, Megan Holt, Adrian Contreras, Miller Huang, Shannon Wong-Michalak, Hao Shao, Robert J Wechsler-Reya, Joanna J Phillips, Jason E Gestwicki, Davide Ruggero, William A Weiss
N-myc mediated translation control is a therapeutic vulnerability in medulloblastoma. Cancer research (2022)
Isabelle R Taylor, Victoria A Assimon, Szu Yu Kuo, Silvia Rinaldi, Xiaokai Li, Zapporah T Young, Giulia Morra, Keith Green, Daniel Nguyen, Hao Shao, Sylvie Garneau-Tsodikova, Giorgio Colombo, Jason E Gestwicki
Tryptophan scanning mutagenesis as a way to mimic the compound-bound state and probe the selectivity of allosteric inhibitors in cells. Chemical science 11 (7) (2020)
Pui Kei Wu, Seung-Keun Hong, Wenjing Chen, Andrew E Becker, Rebekah L Gundry, Chien-Wei Lin, Hao Shao, Jason E Gestwicki, Jong-In Park
Mortalin (HSPA9) facilitates BRAF-mutant tumor cell survival by suppressing ANT3-mediated mitochondrial membrane permeability. Science signaling 13 (622) (2020)
Euan S Polson, Verena B Kuchler, Christopher Abbosh, Edith M Ross, Ryan Koshy Mathew, Hester A Beard, Bárbara da Silva, Andrew N Holding, Stephane Ballereau, Eulashini Chuntharpursat-Bon, Jennifer Williams, Hollie B S Griffiths, Hao Shao, Anjana Patel, Adam J Davies, Alastair P Droop, Paul Chumas, Susan C Short, Mihaela Lorger, Jason E Gestwicki, Lee D Roberts, Robin S Bon, Simon J Allison, Shoutian Zhu, Florian Markowetz, Heiko Wurdak
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice. Science translational medicine 10 (454) (2019)